Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gringeri

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 18, 2018
Comparative analysis of marketed factor VIII products: recombinant products are not alike vis-a-vis soluble protein aggregates and subvisible particlesJ Anzengruber, C Lubich, T Prenninger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 22, 2015
Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trialsA O Oladapo, J D Epstein, E Williams, et al.
Archives of Internal Medicine|March 1, 1991
Suboptimal response to hepatitis B vaccine in drug usersM Rumi, M Colombo, R Romeo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2005
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experimentL G Mantovani, M S Monzini, P M Mannucci, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversionE Santagostino, A Gringeri, D Cultraro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 28, 2011
Understanding FVIII/VWF complex--report from a symposium of XXIX WFH meeting 2010A Gringeri, F A Ofosu, S Grancha, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 12, 2002
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patientsS Royal, W Schramm, E Berntorp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 6, 2007
Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor responseA Gringeri, R Musso, M G Mazzucconi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2008
European principles of haemophilia careB T Colvin, J Astermark, K Fischer, et al.
Blood|December 15, 1990
Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrateP M Mannucci, K A Bauer, A Gringeri, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Journal of Thrombosis and Haemostasis : JTH|April 18, 2018
Comparative analysis of marketed factor VIII products: recombinant products are not alike vis-a-vis soluble protein aggregates and subvisible particlesJ Anzengruber, C Lubich, T Prenninger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 22, 2015
Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trialsA O Oladapo, J D Epstein, E Williams, et al.
Archives of Internal Medicine|March 1, 1991
Suboptimal response to hepatitis B vaccine in drug usersM Rumi, M Colombo, R Romeo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2005
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experimentL G Mantovani, M S Monzini, P M Mannucci, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversionE Santagostino, A Gringeri, D Cultraro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 28, 2011
Understanding FVIII/VWF complex--report from a symposium of XXIX WFH meeting 2010A Gringeri, F A Ofosu, S Grancha, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 12, 2002
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patientsS Royal, W Schramm, E Berntorp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 6, 2007
Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor responseA Gringeri, R Musso, M G Mazzucconi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2008
European principles of haemophilia careB T Colvin, J Astermark, K Fischer, et al.
Blood|December 15, 1990
Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrateP M Mannucci, K A Bauer, A Gringeri, et al.
Pageof 13